Answers are grounded in this paper and cite their sources.
Treatment adherence is one of the key factors influencing the effectiveness of prescribed therapy in oncological diseases. Although adherence is influenced by a broad spectrum of factors, patients’ psychological characteristics remain the least studied. The aim of the current study was to compare the psychological characteristics in cancer patients undergoing chemotherapy who demonstrate different levels of treatment adherence (n = 50; mean age 53.98 ± 12.99 years; 88% women, 12% men). Data collection involved a structured interview to obtain socio-demographic, socio-psychological, and clinical-psychological information, supplemented by a battery of psychometric instruments: the Brief Illness Perception Questionnaire (B-IPQ), the Hospital Anxiety and Depression Scale (HADS), Ways of Coping Questionnaire (WCQ) and the Russian Questionnaire of the Quantitative Assessment of the Adherence to Treatment (QAA-25). It was found that the mean adherence score in the sample corresponded to an overall moderate level of adherence. Regardless of the group (high/middle/low adherence), behavioral aspects of treatment related to lifestyle changes were perceived as less important and more difficult to implement, overall readiness to follow medical recommendations exceeded their subjective importance. The findings confirm a significant association between treatment adherence and several psychological characteristics in cancer patients. Higher adherence level is associated with lower emotional reactivity to illness, reduced perception of illness concern, a greater sense of treatment-related control, less active use of coping strategies associated with seeking social support. Our findings, however, require a cautious interpretation due to potential effects of social desirability, contextual features of the treatment process and limited representativeness of the sample. Overall, the study underscores the importance of considering emotional, cognitive, and personality-related factors in the complex in the development of targeted interventions aimed at improving treatment adherence among patients with oncological diseases.
No takes yet. Share an insight, caveat, or question.
Grin-Yatsenko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: